Bespoke Additive Manufacturing Diagnostic

Launching June 15, 2026. Sold out until launch. Notify list opens now.

---

the five-second epistemology of: additive manufacturing is also known as 3D printing · most of the time you do not need it · most of the time the reason you "need" it is the billing, not the product · the medical device industry charges more for 3D-printed because the insurance reimbursement code allows it · your founder is selling a billing strategy dressed up as a design strategy · low unit volume is not a reason · "we need 3D printing for this geometry" is usually wrong · legitimate additive cases were additive from inception · The Dispatch sources for your own product, not for reverse-engineered ones · The Dispatch reads the gap

FREE ADVICE FIRST. YOU PROBABLY DO NOT NEED THIS ENGINE.

If you are debating whether to additively or subtractively manufacture your part — The Dispatch will save you the engagement fee right now.

Subtractive. There is no benefit to additive in your case. Almost certainly. Save the engineering study. Save the prototyping cycle. Save the unit cost. Save the production schedule. Save the $2,994.99 on this diagnostic.

Buy the Bespoke Subtractive Manufacturing Diagnostic instead. That is the engine The Dispatch recommends to 95% of buyers who come in asking about additive.

The exceptions exist. They are narrow:

• Geometries that genuinely cannot be machined — true internal channels, lattice structures that do load-bearing work, conformal cooling passages in molds
• Production runs under 50 units where amortizing tooling does not pencil out
• Materials only available as powders — certain titanium alloys, certain superalloys
• Patient-specific implants where the clinical case is real, not the billing case

Legitimate additive cases come up early in the process. They are inherent to the product from inception. The geometry could not be machined from the first prototype. The lattice was load-bearing in the first design review. The patient-specific case was the clinical premise on day one. Real additive cases are decided in the engineering sprint where the product was first conceived. They are not decided later, after the reimbursement consultant explained the billing code.

If your case is "we are deciding now whether to make this additive" — the answer is no. Real additive cases do not need to decide. They are additive from the start.

If your real motive is the billing code, do not buy this engine. Do not buy anything from The Dispatch for this decision. Just be honest with yourself about the billing strategy and stop dressing it up as a manufacturing decision.

IF YOU STILL WANT ADDITIVE.

You have read the above. You still want additive. Maybe you are right and The Dispatch is wrong. Maybe you are not, and you know it. Either way — The Dispatch does not argue with your engineer.

The Dispatch will source it.

Print bureau selection, vendor qualification, material certification (metal additive, polymer additive, binder jetting), post-processing pathway, FDA validation if the device is regulated, supply-chain redundancy across the regions The Dispatch sources from. The Dispatch has done it. The Dispatch will do it again. Different tier, same Dispatch.

One condition. The Dispatch sources additive for your own product. Your own design. Your own engineering.

The Dispatch does not source additive on reverse-engineered products. If your engineer is reverse-engineering a big company's product to 3D print it and bill it at the higher reimbursement code — The Dispatch does not source that. Not for IP reasons. The Dispatch does not care about the big company's IP. For competence reasons.

If you have to reverse-engineer the product, your product is worse than the original. If your worse version is then layered with additive manufacturing to chase the reimbursement code — your engineer does not know what he is doing. The Dispatch does not source operations run by engineers who do not know what they are doing.

The Dispatch can tell when an engineer is reverse-engineering. You also know whether your engineer is reverse-engineering. Do not pretend.

Original product, billing-code play included — The Dispatch sources. Reverse-engineered product, billing-code play attached — do not buy. Do not come to The Dispatch for that engagement.

This engine is the diagnostic only. The diagnostic tells you what The Dispatch thinks. If the diagnostic says "do not go additive" and you decide to go additive anyway — fine. The Dispatch does not debate the decision. The Dispatch sources what you decide to buy (subject to the condition above). The Dispatch does not need to agree with the decision to execute it.

If you want sourcing instead of a diagnostic, contact The Dispatch for a sourcing engagement.

THE WRITING TEST.

Tell the founder, the engineering director, or the manufacturing director to put it in writing. 600 words. Plain English. Why additive instead of subtractive. What is the actual technical requirement. What is the unit volume. What is the per-part cost differential.

If they write "the geometry requires it" — hit buy. The geometry rarely requires it. The Dispatch reads the geometry.

If they write "we have low unit volume so 3D printing makes sense" — hit buy. They do not understand subtractive economics at low volume. Subtractive at low volume is cheaper than people think.

If they write "this is an innovative manufacturing approach" or "we are a 3D printed [category] company" — hit buy. The founder is selling a category, not a product.

If they write "the device is medical and gets reimbursed at a higher rate when 3D printed" — do not buy this engine. They have already told you the answer. The answer is billing.

If they write anything that describes a product that already exists from a larger competitor, with your version planned to be additively manufactured to bill at a higher code — do not buy this engine. The Dispatch will not source it either. See condition above.

WHY YOUR FOUNDER WANTS 3D PRINTING.

The 3D printing industry is in the business of creating needs that do not exist. Trade shows. Magazine spreads. "Industry 4.0" decks. Venture-backed startups selling print farms. Consulting firms billing for additive transformation roadmaps. McKinsey published the white paper. Every industry conference has a keynote. Every founder pitch deck has a slide.

The most expensive way to manufacture most parts is additively. The exceptions are narrow. The industry has spent fifteen years convincing buyers the exceptions are broad. They are not.

Medical is the most aggressive seller of the additive argument. The pitch: "the patient anatomy is unique, the device needs to be patient-specific, the only way to deliver patient-specific is additive."

Most of the time, the patient does not need a patient-specific device. The patient needs a device. The device is sold as patient-specific because the billing code for patient-specific pays more. Medicare pays more. Medicaid pays more. The commercial insurance carrier can be billed more. The clinical case is downstream. The billing case is upstream.

If your founder is telling you the device has to be 3D printed because of some "special feature" — the special feature is the reimbursement code, not the patient. The Dispatch names this.

Low unit volume is not a reason either. "We are only making 200 units a year, so subtractive does not make sense" — wrong. Subtractive at 200 units a year is straightforward. CNC shops in Ohio, Wisconsin, Guangdong, and Tijuana run that all day. Soft tooling, machined fixtures, manual finishing. Cheaper than additive. Faster than additive. More reliable than additive.

The Dispatch reads against the substrate, not against the founder's deck.

WHAT THE DIAGNOSTIC NAMES.

• The actual manufacturing requirement — named, against your part geometry, tolerance spec, material spec, and unit volume
• The subtractive comparison — named, with realistic unit-cost numbers from real CNC shops in real regions
• The billing argument, if it exists — named, separated from the engineering argument
• The founder's pitch deck claim about additive — named, mapped against operational reality
• The trade-show vendor's quote — named, against what the part actually requires
• The five-year cost trajectory — additive cost-down vs subtractive cost-down at your volume
• The supply-chain footprint — additive print bureaus vs subtractive job shops in the regions you can actually buy from
• The regulatory implication — if medical, the FDA validation work that additive triggers that subtractive does not
• The timing question — was this an additive case from inception, or did additive enter the conversation after someone read the reimbursement code
• The reverse-engineering question — is your engineer copying a larger competitor's product, and is the additive layer the billing strategy on top of the copy

You walk into the engineering meeting with the diagnostic. The founder revises the deck. The CTO asks a different question. The manufacturing decision gets remade. Or confirmed. Either way you have your answer in 48 hours.

48-hour delivery. Cards included.

HOW THIS WORKS.

You click buy. You upload the part geometry (STEP, IGES, STL, whatever you have), the spec, the unit volume, the founder's pitch on why it has to be additive. The diagnostic lands in 48 hours.

No scoping call. No statement of work. No master services agreement. No project manager. No relationship manager. No engagement letter. No kickoff meeting.

You give the basic requirements. The Dispatch ships.

This engine reads one part, or one part family, against the additive-vs-subtractive question. If you need full DFM, supply-chain sourcing, FDA validation pathway, or production-line build — different tier, same Dispatch.

THE 48-HOUR CLOCK.

You are buying time. Not labor.

If the diagnostic needs more time, that is The Dispatch's call. It will not run to 96 hours because The Dispatch is debating your engineering team about whether the lattice structure "is really load-bearing."

PART TWO. WHAT HAPPENS AFTER THE DIAGNOSTIC LANDS.

The diagnostic lands in 48 hours. The Dispatch's work is finished. Yours starts.

Your engineering team will not like the diagnostic. They will tell you The Dispatch does not understand the geometry, the materials science, the cooling channels, the lattice topology, the assembly constraint, the design intent. Fifty reasons. The Dispatch does not show up to defend the diagnostic.

Your founder will really not like the diagnostic. If the founder pitched the company as "the 3D printed [X]" — the diagnostic is naming that pitch as a billing strategy. The founder will tell you The Dispatch does not understand the company, the market, the patient, the customer, the clinical case. The Dispatch does not chase the founder.

The 3D printing vendor will really really not like the diagnostic. They have spent two years selling you on the print farm. They will counter-quote. They will offer free prototyping. They will fly an applications engineer to your office. The Dispatch does not care.

If your engineering team likes the diagnostic, the engine probably failed. They are using it to win an internal argument they were already going to win. The Dispatch does not chase them either.

This is a blueprint, not a debate. The Dispatch ships blueprints. The Dispatch does not debate manufacturing strategy with your engineering committee.

If you do not have authority over the manufacturing decision — do not buy. Engineering reports up to the CTO. The CTO reports up to the CEO. If the diagnostic needs to clear all three, the engine is not for you.

The diagnostic is for you to act on. Part two is your job.

CAVEAT EMPTOR. REFUNDS ARE NARROW. TALK TO YOUR LAWYER BEFORE BUYING.

The Dispatch has standing positions, written in full and published at bespokeontology.com/pages/caveat-emptor. They are non-negotiable. By clicking buy, you agree to them. Read the full page before clicking.

The positions most relevant to this engine: Legal is probably wrong (your regulatory affairs person scared of the FDA validation pathway). Marketing, sales, and the founder are probably wrong in the opposite direction (selling a billing strategy as a clinical strategy). The headcount answer is wrong (you do not need a dedicated additive engineering team). "Strategic" is the word people use when they cannot say what they mean ("strategic 3D printing partner" = the vendor captured your engineering org).

Refunds are narrow. The Dispatch refunds genuinely bad work — a factual error, a structural failure, internal logic that does not hold. The Dispatch does not refund because your engineering team disagrees with the diagnostic. The engine is named "Bespoke Additive Manufacturing Diagnostic" because most diagnostics come back saying you do not need additive. The engineering team disagreeing was the engine spec.

Talk to your lawyer before buying, not after. The Dispatch does not have a customer-success organization to debate refund requests. That is part of how the price is structured. If you are uncertain, do not buy.

KNOW WHAT YOU ARE BUYING.

The Shopify experience is built for speed. You can buy in sixty seconds.

Read the page first. Read every page first. The Dispatch wrote each one so you can understand what you are buying before you click. The Dispatch will not retro-scope based on a conversation you did not have.

And read the free advice at the top of this page again before clicking. You probably do not need this engine. Buy subtractive instead. Or, if you have read the page and still want additive on an original product (not a reverse-engineered one), contact The Dispatch for sourcing. The Dispatch will source. The Dispatch will not debate.

THE PRICE.

$2,994.99. Five-dollar Substack discount applied. Click. Pay. Upload the part geometry, the spec, the unit volume, the founder's pitch.

The diagnostic lands.